HUTCHMED (China) Limited
Stock Forecast, Prediction & Price Target
HUTCHMED (China) Limited Financial Estimates
HUTCHMED (China) Limited Revenue Estimates
HUTCHMED (China) Limited EBITDA Estimates
HUTCHMED (China) Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $356.12M N/A | $426.40M 19.73% | $837.99M 96.52% | Avg: $839.86M Low: $811.34M High: $886.35M avg. 0.22% | Avg: $1.03B Low: $958.65M High: $1.14B avg. 23.59% | Avg: $1.58B Low: $1.46B High: $1.74B avg. 52.34% | Avg: $1.45B Low: $1.34B High: $1.60B avg. -7.87% |
Net Income
% change YoY
| $-227.65M N/A | $-410.13M -80.15% | $100.78M 124.57% | Avg: $6.93M Low: $2.60M High: $26.59M avg. -93.11% | Avg: $102.36M Low: $77.93M High: $137.84M avg. 1376.18% | Avg: $222.09M Low: $200.01M High: $251.70M avg. 116.97% | Avg: $2.19B Low: $1.98B High: $2.49B avg. 890.13% |
EBITDA
% change YoY
| $-329.26M N/A | $-401.10M -21.81% | $25.52M 106.36% | Avg: $-553.72M Low: $-584.37M High: $-534.92M avg. -2269.09% | Avg: $-684.38M Low: $-754.55M High: $-632.04M avg. -23.59% | Avg: $-1.04B Low: $-1.14B High: $-962.86M avg. -52.34% | Avg: $-960.47M Low: $-1.05B High: $-887.02M avg. 7.87% |
EPS
% change YoY
| -$0.29 N/A | -$0.48 -65.51% | $0.59 222.91% | Avg: $0.01 Low: $0 High: $0.03 avg. -97.56% | Avg: $0.12 Low: $0.09 High: $0.16 avg. 764.34% | Avg: $0.26 Low: $0.23 High: $0.29 avg. 105.86% | Avg: $2.53 Low: $2.28 High: $2.87 avg. 890.13% |
Operating Expenses
% change YoY
| $426.21M N/A | $522.99M 22.70% | $436.23M -16.59% | Avg: $228.86M Low: $221.09M High: $241.53M avg. -47.53% | Avg: $282.87M Low: $261.23M High: $311.87M avg. 23.59% | Avg: $430.93M Low: $397.97M High: $475.11M avg. 52.34% | Avg: $396.98M Low: $366.62M High: $437.69M avg. -7.87% |
FAQ
What is HUTCHMED (China) Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 572.54% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is 2.60M, average is 6.93M and high is 26.59M.
What is HUTCHMED (China) Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 17.07% in 2025-2028.
We have gathered data from 11 analysts. Their low revenue estimate is $811.34M, average is $839.86M and high is $886.35M.
What is HUTCHMED (China) Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 415.69% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is $0, average is $0.01 and high is $0.03.
What is the best performing analyst?
In the last twelve months analysts have been covering HUTCHMED (China) Limited stock. The most successful analyst is Jack Lin.